Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia

National Medical Journal of China

Volumn 87, Issue 20, 2007, Pages 1384-1388

  Wang, Dan ^a   Ke, Xia Yan ^b   Wang, Jing ^b   Xu, Fang ^b   Hu, Yong Fang ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b NONE

Author keywords

Acute; Complete remission rate; Genes; Leukemia; MDR; Myelocytic; Polymorphism; Single nucleotide

Indexed keywords

ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN 1;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CHI SQUARE TEST; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; EXON; FEMALE; FISHER EXACT TEST; GENOTYPE; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PROBABILITY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VOLUNTEER;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REMISSION INDUCTION;

EID: 34447530205     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chinese source.
2. Illmer T, Ulrich S, Thiede C, et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res, 2002, 62: 4955-4962.
3. Kim DH, Park JY, Sohn SK, et al. Multidrug resistance-1 gene polymorphis -ms associated with treatment outcomes in de novo acute myeloid leukemia. Int J Cancer, 2006, 118: 2195-2201.
4. Zhang WX, Chen GL, Zhang W, et al. MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males. Clin Chim Acta, 2005, 359: 46-52.
5. Juliano RL, Ling V. A surface glycoprotein, modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta, 1976, 455: 152-162.
6. Leonor S, Isidro J, Guillermo M, et al. P-glycoprotein expression and prognostic value in acute myeloid leukemia. Haematologica, 1998, 83: 783-787.
7. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci, 2000, 97: 3473-3478.
8. Ameyaw MM, Regateiro F, Li T, et al. MDR1 pharmacogeneics: frequency of the C3435t mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics, 2001, 11: 217-221.
9. Owen A, Chandler B, Bray PG, et al. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4. J Virol, 2004, 78: 12022-12029.
10. Nakamura T, Sakaeda T, Horinouchi M, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther, 2002, 71: 297-303.
11. Siegmund W, Ludwig K, Giessmann T, et al. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol. Clin Pharmacol Ther, 2002, 72: 572-583.
12. Kim DH, Lee NY, Back JH, et al. Prognostic scoring model based on multi-drug resistance status and cytogenetics in adult patients with acute myeloid leukemia. Leuk Lymphoma, 2006, 47: 461-467.